Global Blood Therapeutics (GBT) Cash Flow Statement

Click line-items for a historical chart and %

Cash Flows From Operating Activities:
Net income
Depreciation and amortization
Amortization of deferred consulting expenses
Amortization of stock-based compensation expense
Equity loss (gain) of unconsolidated entity
Provision for doubtful accounts and inventory valuation allowance
Gain on disposal of fixed asset
Change in fair value of warrants
Change in accounts receivable, net
Change in Inventories, net
Change in other receivables and other assets
Change in advance to suppliers
Change in accounts payable
Change in accrued expenses, other payables and advances from customers
Change in income tax payable
Net Cash Provided By Operating Activities
Cash Flows From Investing Activities:
Deposit for property, plant and equipment
Purchase of property, plant and equipment
Proceeds from disposal of property, plant and equipment
Cash acquired from business combination
Acquisition of subsidiary
Acquisition of intangible assets
Net Cash (Used in) Investing Activities
Cash Flows From Financing Activities:
Repayment of bank loan
Net cash provided by (used in) financing activities
Effect of Exchange Rate Changes on Cash
Increase in cash
Cash - Beginning of period
Cash - End of period
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest expense
Income taxes

Entities mentioned with GBT